Published in J Natl Cancer Inst on October 01, 1965
The functions of the thymus system and the bursa system in the chicken. J Exp Med (1966) 4.07
Suppression of immunoglobulin class synthesis in mice. I. Effects of treatment with antibody to -chain. J Exp Med (1972) 3.32
Immune responses in congenitally thymus-less mice. II. Quantitative studies of serum immunoglobulins, the antibody response to sheep erythrocytes, and the effect of thymus allografting. Clin Exp Immunol (1973) 2.48
The inhibition of granuloma formation around Schistosoma mansoni eggs. II. Thymectomy. Am J Pathol (1967) 2.23
Thymectomy and cancer--a follow-up study. Br J Cancer (1972) 1.40
Consequences of neonatal thymectomy in New Zealand black mice. Clin Exp Immunol (1967) 1.32
Hyperimmunoglobulinaemia, T-cell deficiency and plasmacytosis in RFM mice with host versus graft disease induced by the perinatal inoculations (T6XRFM)F1 spleen cells. Clin Exp Immunol (1975) 0.97
Thymus dependence of the IgA response to sheep erythrocytes. Immunology (1975) 0.93
Frequencies of background cytoplasmic Ig-containing cells in various lymphoid organs of athymic and euthymic mice as a function of age and immune status. Immunology (1984) 0.90
Response of mice to rabbit Fab' 2 and Fab'. Thymus independence of IgM response and thymus dependence of IgG response. Immunology (1972) 0.82
Immunological activity of the thymus. Can Med Assoc J (1966) 0.75
Study of mesenteric lymph nodes in neonatally thymectomized rats with regard to cell types and gamma globulin content of cells. Am J Pathol (1967) 0.75
The thymus, delayed hypersensitivity and autoimmunity. Proc R Soc Med (1968) 0.75
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci U S A (1979) 6.93
Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N Engl J Med (1989) 4.20
AIDS--an immunologic reevaluation. N Engl J Med (1984) 3.53
The acquired immunodeficiency syndrome. Ann Intern Med (1983) 3.49
Immunoglobulin changes in disease: quantitation on the basis of heavy polypeptide chains, IgG (gammaG), IgA (gammaA), and IgM (gammaM), and of light polypeptide chains, type K (I) and type L (II). J Clin Invest (1965) 3.00
Extrasalivary lymphoid abnormalities in Sjögren's syndrome (reticulum cell sarcoma, "pseudolymphoma," macroglobulinemia). Am J Med (1967) 2.92
Limited periods of gene expression in immunoglobulin-synthesizing cells. Science (1969) 2.77
Effects of antilymphocyte serum on virus oncogenesis. Proc Soc Exp Biol Med (1968) 2.63
Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders. Am J Med (1984) 2.60
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med (1997) 2.55
Relation between sexual practices and T-cell subsets in homosexually active men. Lancet (1983) 2.46
Accelerated course of human immunodeficiency virus infection in gay men who conceal their homosexual identity. Psychosom Med (1996) 2.40
Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry (1993) 2.38
THE METABOLISM OF NORMAL PLASMA PROTEINS AND GAMMA-MYELOMA PROTEIN IN MICE BEARING PLASMA-CELL TUMORS. J Clin Invest (1961) 2.32
Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J Immunol (1989) 2.27
Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol (1999) 2.15
Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol (1987) 2.11
CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr (1989) 2.10
Antibodies and immunoglobulins. II. Normal development and changes in disease. JAMA (1965) 2.10
The immunoglobulins of mice. VI. Response to immunization. J Immunol (1965) 2.08
A mouse tumor-specific transplantation antigen is a heat shock-related protein. Proc Natl Acad Sci U S A (1986) 2.06
Inhibition of tumor growth by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A (1969) 2.00
Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma. Clin Immunol Immunopathol (1983) 1.91
Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol (1998) 1.90
Early effects of HIV on CD4 lymphocytes in vivo. J Immunol (1987) 1.87
Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol (1993) 1.86
A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. J Infect Dis (1990) 1.75
A common transformation-related protein in murine sarcomas and leukemias. Cold Spring Harb Symp Quant Biol (1980) 1.74
A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry (1990) 1.71
Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Res (1988) 1.70
Cognitive processing, discovery of meaning, CD4 decline, and AIDS-related mortality among bereaved HIV-seropositive men. J Consult Clin Psychol (1998) 1.69
Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci U S A (2001) 1.68
Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures. Clin Diagn Lab Immunol (1998) 1.65
Primary amyloidosis. Clinical, immunochemical and immunoglobulin metabolism. Studies in fifteen patients. Am J Med (1969) 1.60
Biological and biochemical properties of Nonidet P40-solubilized and partially purified tumor-specific antigens of the transplantation type from plasma membranes of a methylcholanthrene-induced sarcoma. Cancer Res (1977) 1.57
Optimism is associated with mood, coping, and immune change in response to stress. J Pers Soc Psychol (1998) 1.55
Use of insoluble antibody for quantitative determination of small amounts of immunoglobulin. J Immunol (1969) 1.51
Serum soluble CD8 molecule is a marker of CD8 T-cell activation in HIV-1 disease. AIDS (1991) 1.50
Human lymphocyte membrane (HL-A) alloantigens: isolation, purification and properties. J Immunol (1969) 1.50
Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes. J Immunol (1984) 1.49
Experimental murine amyloid. IV. Amyloidosis and immunoglobulins. J Immunol (1969) 1.48
Metabolism of human immunoglobulin D (IgD). J Clin Invest (1966) 1.46
Defective monocyte function in acquired immune deficiency syndrome (AIDS): evidence from a monocyte-dependent T-cell proliferative system. J Clin Immunol (1985) 1.46
Influence of thymosin on immunological competence of lymphoid cells from thymectomized mice. Nature (1968) 1.45
Evidence for several cell populations active in antibody dependent cellular cytotoxicity. J Immunol (1973) 1.44
Proliferation and differentiation of lymphoid cells: studies with human lymphoid cell lines and immunoglobulin synthesis. Ann N Y Acad Sci (1971) 1.43
Maternal HBsAg status and infant size--a Faustian bargain? J Viral Hepat (2012) 1.43
Synthesis of immunoglobulins by human cell lines in tissue culture. J Immunol (1967) 1.42
Studies of a Size Cross in Mice, II. Genetics (1936) 1.40
High-frequency cotransfer of the transformed phenotype and a tumor-specific transplantation antigen by DNA from the 3-methylcholanthrene-induced Meth A sarcoma of BALB/c mice. Proc Natl Acad Sci U S A (1981) 1.38
Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation. J Clin Microbiol (1987) 1.37
Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells. J Immunol (1987) 1.34
Studies of thymic function with emphasis on the role of the thymus in oncogenesis. Cancer Res (1966) 1.34
Amyloidosis induced in mice by Escherichia coli endotoxin. Science (1968) 1.30
The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes. Clin Immunol (1999) 1.25
Studies of the significance of tumor antigens in induction and repression of neoplastic diseases: presidential address. Cancer Res (1969) 1.24
Immunoglobulin synthesis in vitro by established human cell lines. Science (1966) 1.24
Multiple skin tumors in mice following a single painting with 9:10 dimethyl-1:2 benzanthracene. Am J Pathol (1941) 1.23
Heterologous and homologous skin-sensitizing activity of mouse 7S gamma 1- and 7S gamma 2-globulins. Nature (1965) 1.20
Primary amyloidosis. Ann Intern Med (1968) 1.20
Immune system changes after the death of a partner in HIV-positive gay men. Psychosom Med (1996) 1.20
Phenotypic and functional characteristics of circulating monocytes of elderly persons. Exp Gerontol (1999) 1.19
Murine amyloid. II. Transfer of an amyloid-accelerating substance. Arthritis Rheum (1969) 1.19
The component fragments obtained by acid dissociation of papain-solubilized H-2 molecules. J Immunogenet (1976) 1.18
Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis. AIDS (1990) 1.17
Immune-cell augmentation (with altered T-subset ratio) is common in healthy homosexual men. N Engl J Med (1983) 1.17
Solubilization of human leucocyte membrane isoantigens. Nature (1968) 1.16
Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update. Ann Intern Med (1987) 1.16
Immunogenic properties of soluble cytosol fractions on Meth A sarcoma cells. Cancer Res (1980) 1.16
Dissection or rupture of a popliteal cyst. A syndrome mimicking thrombophlebitis in rheumatic diseases. Arch Intern Med (1974) 1.15
Inhancement activity of mouse immunoglobulin classes. J Immunol (1967) 1.14
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood (1987) 1.14
Purification and biochemical properties of tumor-associated transplantation antigens from methylcholanthrene-induced murine sarcomas. Proc Natl Acad Sci U S A (1982) 1.13
Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens. Clin Immunol Immunopathol (1992) 1.12
Brief recording: sausage cyanosis--acquired methemoglobinemic nitrite poisoning. N Engl J Med (1967) 1.10
Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia. N Engl J Med (1980) 1.10
Abnormal serum immunoglobulins occurring with reticular neoplasms in a inbred strain of mouse. J Natl Cancer Inst (1967) 1.10
Some biologic, immunogenic, and morphologic effects in mice after infection with a murine sarcoma virus. I. Biologic and immunogenic studies. J Natl Cancer Inst (1968) 1.10
Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J Acquir Immune Defic Syndr (1988) 1.08
Immunologic classification of lymphocytic leukemias based on monoclonal antibody-defined cell surface antigens. Blood (1982) 1.08
Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change. Clin Immunol Immunopathol (1991) 1.08
Autoimmune panleukopenia. N Engl J Med (1976) 1.07
Defects in cell-mediated immunity during growth of a syngeneic simian virus-induced tumor. Int J Cancer (1975) 1.07
Immunological changes in lymphadenopathy virus positive and negative symptomless male homosexuals: two years of observation. Lancet (1985) 1.07
Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity. J Immunol (1974) 1.06
Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol (1994) 1.06
Immunologic responsiveness and the induction of experimental neoplasms. Cancer Res (1966) 1.05
The soluble antigens of BALB/c sarcoma Meth-A: a relationship between a serologically defined tumor-specific surface antigen (TSSA) and the tumor-associated transplantation antigen (TATA). Transplant Proc (1981) 1.05
Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes. Clin Diagn Lab Immunol (1997) 1.05
Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med (1984) 1.04
Antibody dependent cellular cytotoxicity: cytotoxicity mediated by non t-lymphocytes. Clin Immunol Immunopathol (1974) 1.03
Regeneration of T cell subpopulations after bone marrow transplantation: cytomegalovirus infection and lymphoid subset imbalance. J Immunol (1982) 1.02
Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS (1993) 1.02
Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection. J Infect Dis (1999) 1.02
Notation for human immunogobulin subclasses. Bull World Health Organ (1966) 1.01
Melanosomal proteins as melanoma-specific immune targets. Melanoma Res (1997) 1.01
2 types of lambda polypeptide chains in human immunoglobulins. Science (1967) 1.01